Show Screener



CTLT $52.05

0.45 (0.9%)


CTLT Profile

MEMBERSHIP
--
SECTOR
Health Care
MARKET CAPITALIZATION

$8 Billion

Mid-Cap
Catalent is a specialty and generic drug manufacturing company. The company focuses on advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The vast majority of Catalent's sales are generated in the United States, followed by Europe and the rest of the world. Most of the company's sales are derived from branded drug products. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

CTLT Earnings

EPS

-0.05

P/E

N/A

Q2 Earnings for Apr, May & Jun

Tue, Aug 27, 2019

Since Earnings Report

CTLT -4.1%

Q3 Earnings for Jul, Aug & Sep

Tue, Nov 5, 2019

Since Earnings Report

CTLT +3.6%

CTLT Dividend

Dividend Yield

0.00%

Dividend Rate

$0.00

Ex-Dividend Date

--

Dividend Pay Date

--

Dividend Frequency

--

Dividend Payments

--

CTLT Charts

All Time High $58.38 Tue, Jul 30, 2019


CTLT Industry Competitors


DRUG MANUFACTURERS
Novartis AG
Astrazeneca
GlaxoSmithKline
Bausch Health Companies Inc. Common Stock
Elanco Animal Health
The Medicines Co
Dr. Reddy's Laboratories Ltd Common Stock
Canopy Growth Corporation Common Stock
Horizon Pharma PLC
Taro Pharmaceutical Industries Ltd



Symbol MC DY Price Day YTD
CTLT $7.62 0.00% $52.05 0.9% 68.4%




Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com



    TOP    

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy Terms Of Service Privacy Policy